Head-to-head · Cost-Efficiency Index
Spry vs RX Bella
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Spry
Shoppers who want compounded GLP-1 bundled with anti-aging peptides from one named founding team.
Visit SpryRX Bella
Someone comparing microdose against oral against injection who will get a firm figure in writing before starting.
Visit RX BellaThe verdict
Spry and RX Bella tie on the Cost-Efficiency Index at 67/100, so neither wins outright on the numbers. For most shoppers we'd start with Spry (ranked #140, a hair above #141) — Shoppers who want compounded GLP-1 bundled with anti-aging peptides from one named founding team. But RX Bella is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Spry.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Spry | RX Bella |
|---|---|---|
| Cost-Efficiency Index | 67/100 | 67/100 |
| Semaglutide / mo | $199/mo (all doses, compounded) | From $249/mo for the injection — a published floor, not a committed rate |
| Tirzepatide / mo | $299/mo (all doses, compounded) | From $299/mo for the injection — the same floor treatment |
| Semaglutide / yr (modeled) | $2,388 | $2,988 |
| Tirzepatide / yr (modeled) | $3,588 | $3,588 |
| Coverage | Coverage not published | Nationwide telehealth, claimed but not enumerated |
| Oral / sublingual | No | Yes |
| Brand-name access | Yes | Compounded only |
| Rank here | #140 | #141 |
Spry
67/100Where the value is
- Real, named founding team with individual bios — confirmed live on the About page
- Pricing shown directly on the homepage and product pages, no sign-up wall required
- Explicitly describes its GLP-1s as compounded rather than leaving formulation ambiguous
The tradeoffs
- No dose-tier price breakdown is published for either drug
- No compounding pharmacy is named anywhere on the pages checked
RX Bella
67/100Where the value is
- Four routes carry a figure on one page before any intake: microdose, oral, semaglutide injection and tirzepatide injection
- Nothing in the catalog is struck through — no invented "was" price and no expiring offer
- "$0 if you're not approved" is stated plainly and repeatedly
The tradeoffs
- The hero's "from $199/mo" is the microdose, not either injection
- Every figure is a floor with no dose ladder, and the eight-screen intake reaches an email gate without showing a price
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.